Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.
about
Stenotrophomonas maltophilia: an emerging global opportunistic pathogenEvaluation of meropenem regimens suppressing emergence of resistance in Acinetobacter baumannii with human simulated exposure in an in vitro intravenous-infusion hollow-fiber infection model.Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control StudyEfflux-mediated antimicrobial resistance.Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?Stenotrophomonas maltophilia drug resistance.The use and risks of antibiotics in critically ill patients.Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr.
P2860
Q26995336-9A6A398F-3526-48C9-AAD3-7BEA4B5EDC9DQ34596344-4759373A-795D-4008-901A-7A537B0D206CQ35711892-19812BD1-65FA-48FF-838C-04548075BFA0Q36138147-7FE701CD-2E78-4FC1-8830-AEB4676FB3CFQ37229067-338C073C-3332-4041-9C11-C80BFB3AA10DQ37544565-EC0C72C6-78DC-4EC6-8847-EEECFDB694ADQ37573751-6546061F-D400-4DD5-B217-F2B7A3F16B78Q38767901-887D7488-9994-47CD-A1C1-79063AF2874BQ41140793-12DE9B35-8A91-4AF6-936D-1C6F2202BC52
P2860
Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Activities of ciprofloxacin an ...... kinetic-pharmacodynamic model.
@en
type
label
Activities of ciprofloxacin an ...... kinetic-pharmacodynamic model.
@en
prefLabel
Activities of ciprofloxacin an ...... kinetic-pharmacodynamic model.
@en
P2093
P2860
P1476
Activities of ciprofloxacin an ...... kinetic-pharmacodynamic model.
@en
P2093
Boubakar B Ba
Claudine Quentin
Hala Feghali
Marie-Claude Saux
P2860
P304
P356
10.1128/AAC.48.3.946-953.2004
P407
P577
2004-03-01T00:00:00Z